Participated · Equity · Nov 2025

Green Spot Technologies develops and manufactures fermented, upcycled ingredients that can partially or fully replace cocoa in a variety of recipes. Using solid-state fermentation, the company transforms plant-based raw materials such as fava beans, grape pomace and other local fibers into powders, fillings and chocolate-style chips marketed under its new MILATEA brand. These ingredients are positioned to lower cost and deliver up to an 80 % reduction in CO₂e emissions, providing customers with a measurable Scope 3 footprint benefit. Production currently takes place at the firm’s facility in Carpentras, France, and the newly raised capital will allow it to expand output ten-fold—from 100 t to 1,000 t per year. The company plans to deepen its presence across bakery, pastry and confectionery markets while collaborating with chefs, researchers and industrial partners to make “sustainable indulgence” scalable. Most MILATEA products are vegan, with plant-based alternatives available for any that are not.

Led · Equity · Aug 2025

Cropin describes itself as the world’s largest deployed AI platform for food and agriculture, offering an AI-powered decision-support system for farmers and agribusinesses. Its core product, FIRST Potato, integrates crop-specific intelligence, real-time field data from sensors, satellite imagery, weather stations, IoT devices, Cropin’s proprietary data models, and predictive analytics to deliver plot-specific daily advisories. The platform helps farmers optimize irrigation, input usage, and residue management to adopt regenerative practices without compromising yield or quality, improving soil health and reducing environmental footprint. Cropin has secured a €700,000 AI deal under EIT Food’s Impact Funding Framework to scale the FIRST Potato deployment across Europe. Planned activities include scientific validation on pilot farms in Denmark and commercial pilots with two potato processors in Germany and the UK, in partnership with Aarhus University. The company is actively engaging in strategic commercial partnerships and is in advanced discussions with several UK and European agri-food brands, expecting to close multiple pilots before the end of the current financial year. Cropin offers an intelligent agriculture cloud platform (Cropin Cloud) and a suite of AI, machine-learning and remote-sensing SaaS solutions that help agribusinesses digitize operations from farm to fork. The company provides actionable, near–real-time farm data and predictive intelligence across crop types and geographies. Cropin reports partnerships with 250+ organizations, has digitized over 16 million acres, reached nearly 7 million farmers, and built intelligence for 400+ crops and 10,000+ crop varieties in 56 countries. Founded in 2010 and headquartered in Bangalore, Cropin focuses on making farms and harvests traceable, predictable, and sustainable. The company plans to expand Cropin Cloud’s capabilities, invest in go-to-market efforts, and develop next-generation predictive intelligence through Cropin AI Labs. Cropin says the new funding will support regional and industry expansion and solutions that address sustainable agriculture and global food security. CropIn offers SaaS and data solutions—notably SmartFarm (farm and agronomy management) and SmartRisk (machine-learning predictive analytics)—that help agri-enterprises improve efficiency, traceability, productivity, and sustainability across crop value chains. SmartRisk combines computer vision, deep learning, multispectral imagery, field scouting data, and hyperlocal weather to analyze over 388 crops and nearly 9,500 variants across trillions of data points. The company reports SmartRisk has processed more than 160 million hectares, has impacted 13 million acres and 4 million farmers to date, and could potentially reach 70 million farmers in the next 3–5 years. Smallholder farmers served by CropIn’s platforms have seen crop-yield increases of nearly 25% in the first year after adopting recommended practices. CropIn is investing the new capital to deepen AI capabilities, continue innovating SmartRisk, and expand globally—recently opening an Amsterdam office and hiring local leaders to drive growth in Europe. With partnerships spanning development finance institutions and government entities in 52 countries, CropIn focuses on digitization, predictability, traceability, financial inclusion, climate-smart agriculture, and sustainability. CropIn provides SmartFarm, a ground-to-cloud technology platform for plot-level farm management that is deployed through agribusinesses' field agents to enable B2B2F operations. The company also develops a machine-learning-based risk product called SmartRisk. It currently monitors about 3 million acres across 2 million farmers and serves 180+ customers, including large agribusinesses, banks, government bodies and development agencies, across 29 countries. CropIn plans to scale its platform in India and globally to monitor more than 10 million actively monitored acres across 7 million farmers. The company is co-founded by Krishna Kumar, Kunal Prasad and Chittaranjan Jena and is based in Bengaluru. Financially, the startup has raised a total of $12M to date. CropIn Technology Solutions is a Bengaluru-based agri-tech startup founded in 2010 by Krishna Kumar that provides a cloud-based software platform to help farmers track produce and consignments. Its offering includes enterprise resource planning and business intelligence with a built-in traceability system and tools to manage the field workforce. The platform collaborates with participants across the supply chain to monitor the status of farm produce. CropIn plans to invest the recent funding in technology, data science and predictive technologies to detect and predict crops in different regions. The company has raised about $4 million to date; the current pre-Series A amount was undisclosed. In August 2016 it raised $2 million from Denmark’s Sophia Investment ApS in a transaction that valued the company at $12 million.

Participated · Seed · Jun 2025

PFx Biotech builds a precision fermentation platform to produce bioidentical human milk proteins such as lactoferrin for use in advanced nutrition products. Its proteins are non-GMO, dairy- and animal-free, highly bioactive, easily digestible and aimed to be allergy-free and suitable across life stages including infant, elderly and sports nutrition. The company plans to scale up production to pre-industrial levels, establish bespoke labs, and grow its team. PFx is actively exploring strategic collaborations across R&D, scale-up, and go-to-market opportunities. Financially, it closed a €2.5 million Seed round and simultaneously secured a €2.5 million EIC Accelerator grant to support scale-up. The team brings experience in dairy proteins, fermentation, molecular biology, scale-up and open innovation, with a sustainability focus.

Participated · Equity · May 2025

NoMy is an Oslo-based fermentation technology company that produces mycoprotein — a sustainable protein derived from fungi — by converting food-industry side streams. Its core product is mycoprotein produced via fungal fermentation; the company says its technologies are proven, scalable and cost-effective. NoMy plans to scale deployment and commercialisation of these technologies, leveraging a partnership with Nippon Beet Sugar Manufacturing (Nitten) to utilise resources from the beet sugar manufacturing process. The company raised a €1.25 million equity investment led by Nitten to support that scaling and commercialisation. Founded in 2020 by Ingrid Dynna and David Andrew Quist, the founders combine commercial and scientific expertise in marketing, strategy and microbiology. NoMy aims to supply sustainable food and aquafeed ingredients and expand partnerships across Japan, Norway and Europe to diversify protein supplies and promote circular food systems. NoMy develops mycelium-based alternatives spanning novel proteins, alternative meat, biocomposites and bioplastics. The company leverages fungal mycelium to create locally produced materials with minimal resources and a lower ecological footprint. It plans a B2B go-to-market approach focused on partnerships that enable circular business solutions and the use of underutilized biological and industrial resources. NoMy will direct its fresh seed funding toward ongoing R&D on “future green materials” as well as novel foods and alternative proteins. Founders Ingrid Dynna and David Andrew Quis combine tech and microbiology backgrounds and emphasize scalable, cost-efficient production without agricultural land or chemicals. The firm highlights mycelium’s potential to replicate and regenerate nature while displacing fossil-fuel-derived materials.

Participated · Equity · Dec 2024

New Wave Biotech is a London-based startup founded in 2022 that offers an AI-powered Bioprocess Foresight platform to simulate bioprocesses and predict quantified output, costs, and sustainability impact. The platform improves over time by learning from empirical data and is designed to help biomanufacturing teams design smarter, commercialise quicker, and scale greener. The company targets applications across alternative proteins, biochemicals, and biomaterials to reduce emissions and transform supply chains. New Wave plans to use its latest funding to expand its team, explore new markets and customers, and invest in product and technology development. The startup positions its software as a way to shorten long R&D timelines and reduce the high costs of experiments that hinder scale-up. Financially, it has raised €1.2 million in its latest round of equity and grant funding and has previously received grant awards from Innovate UK and investment from Big Idea Ventures. New Wave Biotech builds solutions aimed at helping alternative-protein companies scale quickly, cheaply, and sustainably. The company was selected to join the Big Idea Ventures Accelerator and to join a community of pioneering alt-protein founders. As part of the program it receives pre-seed funding from Big Idea Ventures and is one of the first investments made through Big Idea Ventures' newly launched New Protein Fund II. New Wave Biotech says BIV's expertise, network, and resources will supercharge its growth and support its mission. Through the accelerator it will gain access to Big Idea Ventures' global network and strategic partners to accelerate commercialization and scaling.